Razinodil

This classification denotes a vasodilating agent with the molecular formula C27H34N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UJ1O5LVT0G, chemically known as 3,4,5-trimethoxybenzoic acid ester with 3-(2-hydroxy-3-morpholinopropyl)-6,7,8-trimethoxy-1,2,3-benzotriazin-4(3h)-one but generally known as razinodil, which bears US NIH Compound Identifier 65771. European Medicines Agency schedules Razinodil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10264MIG. The term RAZINODIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). RAZINODIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule razinodil under HS 29349990 and SITC 51579. As of Q4 2014, RAZINODIL remains the US FDA Preferred Term for this commodity. Razinodil bears US NLM identifiers UMLS ID C0613934 and NCI Concept Code C77078. SMILES: O1CCN(CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)Cn2nnc3c(c2=O)cc(OC)c(OC)c3OC)CC1.